Literature DB >> 6668550

An incremental method for the study of the absorption of drugs whose kinetics are described by a two-compartment model: estimation of the microscopic rate constants.

A Gerardin, D Wantiez, A Jaouen.   

Abstract

A method is proposed for estimating the overall absorption kinetics of drugs (expressed as percent of total amount absorbed versus time) from plasma data. It is applicable to the study of drugs whose kinetics can be described by linear one- or two-compartment models. Use is made of an iterative process based on the differential equations of the model and on linear interpolation of plasma data. The method does not require that the overall absorption kinetics should be apparent first-order and/or that the model parameters should be estimated from a previous experiment. It was tested for the influence of data scatter: added noise (CV = 10%) resulted in a variability of percent absorbed versus time of the same order of magnitude. During the calculations, the microscopic rate constants are estimated and optimalized. Data scatter resulted in wide variations in the estimates of the two-compartment model parameters. However, when a sufficiently large number of plasma concentration-time curves were studied, an average model could be determined with a reasonable precision. Model kinetics calculated from the related parameter estimates were in agreement with the theory. The method permits the exploitation of the various plasma concentration-time curves which are available after the development of an orally administered drug.

Mesh:

Substances:

Year:  1983        PMID: 6668550     DOI: 10.1007/bf01058958

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  8 in total

1.  Per cent absorbed time plots derived from blood level and/or urinary excretion data.

Authors:  J G WAGNER; E NELSON
Journal:  J Pharm Sci       Date:  1963-06       Impact factor: 3.534

2.  Application of the Wagner-Nelson absorption method to the two-compartment open model.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1974-12

3.  Problems associated with analysis of pharmacokinetic models.

Authors:  W J Westlake
Journal:  J Pharm Sci       Date:  1971-06       Impact factor: 3.534

4.  New method for calculating the intrinsic absorption rate of drugs.

Authors:  J C Loo; S Riegelman
Journal:  J Pharm Sci       Date:  1968-06       Impact factor: 3.534

5.  Osmotically controlled-delivery of metoprolol in man: in vivo performance of Oros systems with different durations of drug release.

Authors:  J Godbillon; A Gerardin; J Richard; D Leroy; J Moppert
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

6.  A stable method for calculating oral drug absorption rate constants with two compartment disposition.

Authors:  L Saunders; T Natunen
Journal:  J Pharm Pharmacol       Date:  1973-12       Impact factor: 3.765

7.  Pharmacokinetics of cefroxadin (CGP 9000) in man.

Authors:  A Gerardin; J B Lecaillon; J P Schoeller; G Humbert; J Guibert
Journal:  J Pharmacokinet Biopharm       Date:  1982-02

8.  Absorption kinetics and model characteristics of orally administered pirprofen.

Authors:  A Gerardin; R C Luders; W E Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1983-08
  8 in total
  8 in total

1.  Pharmacokinetics of oxiracetam in elderly patients after 800 mg oral doses, comparison with non-geriatric healthy subjects.

Authors:  J B Lecaillon; J P Dubois; H Coppens; T Darragon; W Theobald; G Reumond; H Beck
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Jul-Sep       Impact factor: 2.441

Review 2.  Novel drug delivery systems. An overview of their impact on clinical pharmacokinetic studies.

Authors:  P S Banerjee; J R Robinson
Journal:  Clin Pharmacokinet       Date:  1991-01       Impact factor: 6.447

3.  The influence of food on the bioavailability of a slow release theophylline preparation.

Authors:  J J Thebault; J M Aiache; F Mazoyer; J M Cardot
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

Review 4.  The gastrointestinal absorption of drugs in man: a review of current concepts and methods of investigation.

Authors:  J Hirtz
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

5.  Influence of food on the absorption of metoprolol administered as an Oros drug delivery system to man.

Authors:  J B Lecaillon; P Massias; J P Schoeller; F Abadie
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

6.  Osmotically controlled-delivery of metoprolol in man: in vivo performance of Oros systems with different durations of drug release.

Authors:  J Godbillon; A Gerardin; J Richard; D Leroy; J Moppert
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

7.  Pharmacokinetics of oxiracetam in patients with renal impairment after a 800 mg single oral dose.

Authors:  J B Lecaillon; J P Dubois; H Coppens; T Darragon; G Reumond; N Pozet; J Traeger; G Lambrey
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Jul-Sep       Impact factor: 2.441

8.  Absorption kinetics and model characteristics of orally administered pirprofen.

Authors:  A Gerardin; R C Luders; W E Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1983-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.